Article: Elan nicotine patch to switch to OTC, private-label form

Consumers who want to quit smoking will have a third OTC nicotine patch to choose from late this spring. Elan Corp., based in Dublin, Ireland, with U.S. headquarters in Gainesville, Ga., has received Food & Drug Administration approval for a supplemental New Drug Application to change its nicotine transdermal system patch from prescription to over-thecounter status. The other two OTC nicotine patches currently on the market are SmithKline Beecham's NicoDerm CQ and McNeil Consumer Products' Nicotrol.

As an Rx product, Elan's smoking-cessation aid for adults was marketed as ProStep by WyethAyerst Laboratories. The OTC product will now be marketed and distributed by Perrigo Co., Allegan, ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!